Author:
Christiansen L.,Bygum A.,Jensen A.,Thomsen K.,Brandrup F.,Hørder M.,Petersen N. E.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference28 articles.
1. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio MG, Lambrecht RW (1998) Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 27: 1661–1669
2. Catteau A, Bechtel YC, Poisson N, Bechtel PR, Bonaiti-Pellie C (1995) A population and family study of CYP1A2 using caffeine urinary metabolites. Eur J Clin Pharmacol 47: 423–430
3. Christiansen L, Bygum A, Thomsen K, Brandrup F, Horder M, Petersen NE (1999) Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda. Clin Chem 45: 2025–2026
4. Christiansen L, Bygum A, Jensen A, Brandrup F, Thomsen K, Hørder M, Petersen NE (2000) Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda. Scand J Clin Lab Invest (in press)
5. D’Amato M, Macri A, Griso D, Biolcati G, Ameglio F (1998) Are His63Asp or Cys282Tyr HFE mutations associated with porphyria cutanea tarda? Data of patients from central and southern Italy. J Invest Dermatol 111: 1241–1242
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献